Innocan Pharma Corp (INNO.CN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [CNSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [CNSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | INNO.CN | ||||
| Company | Innocan Pharma Corp | ||||
| Price Information | |||||
| Exchange | CNSX | ||||
| Open | 6.5000 | ||||
| High | 6.5000 | ||||
| Low | 6.5000 | ||||
| Latest | 6.5000 | ||||
| Change | unch | ||||
| % Change | unch | ||||
| Volume | 0 | ||||
| 20-Day Average Volume | 1,655 | ||||
| Previous Close | 6.5000 | ||||
| Industry | N/A | ||||
| Has Options | No | ||||
| Technicals | |||||
| 20-Day Moving Average | 6.5815 | ||||
| 20-Day Raw Stochastic | 58.14% | ||||
| 20-Day Relative Strength | 43.63 | ||||
| Weighted Alpha | -56.14 | ||||
| Today's Opinion | 100% Sell | ||||
| Previous Opinion | 100% Sell | ||||
| Last Month's Opinion | 100% Sell | ||||
| Performance | |||||
| 5-Days | |||||
| %Chg | -2.40% since 04/08/26 | ||||
| Low | 6.0000 on 04/13/26 | ||||
| High | 6.6600 on 04/09/26 | ||||
| 1-Month | |||||
| %Chg | +0.78% since 03/13/26 | ||||
| Low | 6.0000 on 04/13/26 | ||||
| High | 6.8600 on 03/19/26 | ||||
| 3-Month | |||||
| %Chg | -19.75% since 01/15/26 | ||||
| Low | 5.7600 on 02/11/26 | ||||
| High | 11.4400 on 01/29/26 | ||||
| 6-Month | |||||
| %Chg | -59.38% since 10/15/25 | ||||
| Low | 5.7600 on 02/11/26 | ||||
| High | 19.1500 on 11/04/25 | ||||
| Key Statistics | |||||
| Market Capitalization, $K | 29,242 | ||||
| Shares Outstanding, K | 4,499 | ||||
| Annual Sales | 26,612,000 | ||||
| Annual Net Income | -1,124,000 | ||||
| Last Quarter Sales | 4,988,000 | ||||
| Last Quarter Net Income | 1,995,000 | ||||
| 60-Month Beta | -0.85 | ||||
| Per-Share Information | |||||
| Most Recent Earnings | 0.32 | ||||
| Latest Earnings Date | N/A | ||||
| Most Recent Dividend | N/A | ||||
| Next Ex-Dividends Date | N/A | ||||
| Ratios | |||||
| Price/Earnings ttm | N/A | ||||